IRCT20150107020592N31 IRCT 2022-01-09 Shahid Beheshti University of Medical Sciences Evaluation of the therapeutic effect of molnopiravir for patients with Quid 19 Evaluation of the therapeutic effect of molnopiravir for patients with Quid 19 2021-12-16 anticipated 60 Complete https://irct.ir/trial/60926 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment, Randomization description: The groups randomization will performed based on the A and B allocation group. this process will managed by computerizing allocation. 3 covid-19. Intervention group: Patients after evaluation and confirmation of Covid 19 and having entry conditions,Enter the study and then patients are divided into two groups A and B based on simple randomization method.In the first group, patients receive Ramdzivir 200 mg loading dose and then 100 mg intravenously daily for up to 5 days. In addition, they receive mulnopiravir at a dose of 200 mg every 12 hours for up to 5 days.In the second group, Ramdzivir receive the said dose plus placebo every 12 hours for up to 5 days.The rest of the drugs used by the patients are the same in the two groups, then the general condition of the patients, tests and CT scans of the patients are checked.. Yes - There is a plan to make this available What will be shared: All patient information can be published after deleting the name When: It will take a month from the time of application To whom: All professors of medical universities in the country Conditions: Help advance science Where to obtain: professor hashemian in masih daneshvari hospital How to obtain: one month Comments: